Prelude Therapeutics Announces IND Clearance for PRT2527, a HighPRLD: Prelude Therapeutics Incorporated 2021-11-08 09:00:00 Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 InhibitorLongby RocketTickers0
PRLD to 60 (and then to 90)PRLD has retraced to fib 0.95 and is close to the IPO price. I am buying today. First target - 60. Second target - 90.Longby financialSnail886740
Bottom FishingPRLD fell very close to the yearly low after creation of an ugly top. You can measure down from the highest peak in the top to the neckline, then use the magnet to project it downward from the neckline to get a guesstimate of how low the top will take price. Possibly a double bttom if the most recent bottom is in. Appears to be moving. No recommendation by lauralea2
PRLD Short-Mid Term AnalysisIt may pullback from this level before going up again. Not financial advice, do your own DD all the time.Longby turanserin0
$PRLD is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Prelude Therapeutics is a clinical-stage biopharma developing treatments for various cancers. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $26,25; stop-loss — $22,94; take-profit — $36,18. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.Longby KozakHlib1